Fucidin® Cream in the Treatment of Impetigo

Summary

To investigate the clinical and bacteriological efficacy of Fucidin® cream in the treatment of impetigo in paediatric patients. To assess the validity of in vitro susceptibility-testing of S. aureus to fusidic acid as a prediction of clinical and bacteriological outcome in impetigo patients treated with Fucidin® cream. To investigate the genetic relationship between S. aureus-strains isolated from impetigo patients.

Timeline

Start

2004-05

Primary completion

2005-03

Completion

2005-03

Outcome

Met primary endpoint

Stopped (Enrollment): “Enrollment failed”

registry analysis (unspecified test); Fucidin® Cream vs Fucidin® Cream Vehicle; p <0.01; Odds Ratio (OR) 13.2 (95% CI 1.4 to 120.4); NCT00986856 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fusidic Acid	Unknown	—	—

Indications